Results 61 to 70 of about 2,191 (109)

Treatment of Leishmania infantum Infections in Dogs

Microorganisms
Dogs are reservoir hosts of the zoonotic parasite Leishmania infantum, the causative agent of canine leishmaniosis. Antiparasitic drugs that are commonly used in dogs include allopurinol, miltefosine, and meglumine antimoniate.
Melanie Kaempfle, Katrin Hartmann, Michèle Bergmann   +2 more
doaj   +1 more source

In vitro and in vivo activity of meglumine antimoniate produced at Farmanguinhos-Fiocruz, Brazil, against Leishmania (Leishmania) amazonensis, L (L.) chagasi and L (Viannia) braziliensis

Memorias do Instituto Oswaldo Cruz, 2008
The leishmanicidal activity of four batches of meglumine antimoniate, produced in Farmanguinhos-Fiocruz, Brazil (TAMs), was assessed and compared to Glucantime®-Aventis Pharma Ltda.
Eliane de Morais-Teixeira, Alcione S de Carvalho, Jorge CS da Costa, Silvio L Duarte, Jorge S Mendonça, Núbia Boechat, Ana Rabello   +6 more
doaj   +1 more source

Meglumine Antimoniate and Miltefosine Combined With Allopurinol Sustain Pro-inflammatory Immune Environments During Canine Leishmaniosis Treatment

Frontiers in Veterinary Science, 2019
Canine leishmaniosis (CanL) caused by Leishmania infantum is a zoonotic disease of global concern. Antileishmanial drug therapies commonly used to treat sick dogs improve their clinical condition, although when discontinued relapses can occur.
Marcos Ferreira Santos, Graça Alexandre-Pires, Maria A. Pereira, Cátia S. Marques, Joana Gomes, Jorge Correia, Ana Duarte, Lídia Gomes, Armanda V. Rodrigues, Alexandra Basso, Ana Reisinho, José Meireles, David Santos-Mateus, Maria Teresa Villa Brito, Luís Tavares, Gabriela M. Santos-Gomes, Isabel Pereira da Fonseca   +16 more
doaj   +1 more source

Treatment of American tegumentary leishmaniasis in special populations: a summary of evidence

Revista da Sociedade Brasileira de Medicina Tropical, 2013
We aimed to assess and synthesize the information available in the literature regarding the treatment of American tegumentary leishmaniasis in special populations.
Juliana Saboia Fontenele e Silva, Tais Freire Galvao, Mauricio Gomes Pereira, Marcus Tolentino Silva   +3 more
doaj   +1 more source

A cross-sectional study on sociodemographic, clinical, and therapeutic characteristics of a pediatric population with cutaneous leishmaniasis

Asian Pacific Journal of Tropical Medicine
Objective: To characterize the pediatric population with cutaneous leishmaniasis treated at a research center and to determine the therapeutic response and safety of the treatment.
Susana Ríos-Echavarría, Juliana Quintero-Pulgarín, Claudia Beltrán, Liliana López-Carvajal   +3 more
doaj   +1 more source

Retrospective study of 151 patients with cutaneous leishmaniasis treated with meglumine antimoniate

Revista da Sociedade Brasileira de Medicina Tropical, 2005
We retrospectively analyzed a series of 151 cases of cutaneous leishmaniasis treated between 1967 and 1982. One-hundred-and-thirty-nine (92%) patients presented with active lesions and were treated with daily doses of meglumine antimoniate: 81 adults ...
Armando de Oliveira Schubach, Keyla B. Feldman Marzochi, João Soares Moreira, Tânia Maria Pacheco Schubach, Marcelo Lodi Araújo, Antônio Carlos Francesconi do Vale, Sonia Regina Lambert Passos, Mauro Célio de Almeida Marzochi   +7 more
doaj  

Antileishmanial potentials of azacitidine and along with meglumine antimoniate on Leishmania major: In silico prediction and in vitro analysis. [PDF]

PLoS One, 2023
Derakhshani A, Sharifi I, Salarkia E, Keyhani A, Agha Kuchak Afshari S, Iranmanesh B, Lashkarizadeh M, Nejad Biglari H, Lari Najafi M, Bamorovat M.   +9 more
europepmc   +1 more source

2025 ACVIM Forum Research Abstract Program

Journal of Veterinary Internal Medicine, Volume 39, Issue 6, November/December 2025.
wiley   +1 more source

Green Synthesis, Characterization, and Antileishmanial Activity of the Silver Nanoparticles Alone and Along with Meglumine Antimoniate against Leishmania major Infection. [PDF]

Iran J Parasitol, 2023
Majeed QA, Shater AF, Alanazi AD.
europepmc   +1 more source

Correction: Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial. [PDF]

PLoS Negl Trop Dis, 2023
Lago J, Fraga D, Guimarães LH, Lago T, Silva YJ, Lago E, Werneck GL, Bacellar O, Carvalho EM.   +8 more
europepmc   +1 more source